{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_5", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-16 17:14:56", "close_timestamp": 1637082896078, "created": "16/11/2021 17:14:57", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "ba5be715-2c5f-4001-aba8-e38eab17d4ab", "open_date_time": "2021-10-16 17:5:0", "open_timestamp": 1637082300958, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "A study between the Doherty institute and BDI in Australia found that conducting pre clinical trials of Ivermectin in the use against covid found that it helps the body fight the virus in just 48 hours. Ivermectin is already available worldwide and having this medication that supposedly helps against coronavirus will be very important to stopping the pandemic but more funding is needed to be able to progress with more pre clinical testing and clinical testing.", "task_condition": "text", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 595120, "what": "The story is about Ivermectin, an anti parastic drug and its first pre clinical trials resulting in being able to kill or reduce the viral load of covid in 48 hours. ", "when_happened": "few_month_ago", "where_location": "Australia", "who": "Ivermectin, BDI, Doherty Institute", "why": "The story is important because it shares information on a potential drug that will be able to be used to kill covid and potentially save countless lives"}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_5", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-16 16:53:6", "close_timestamp": 1637081586516, "created": "16/11/2021 16:53:09", "department": "Computing", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "cfd81668-e419-4fd2-8a6b-7e8e03d6eb36", "open_date_time": "2021-10-16 16:39:32", "open_timestamp": 1637080772185, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "Nasdaq published their results on their trials of novavax for the use against covid. It is important for the vaccine to succeed because places like Mexico have an increase in covid rates and their supplies to vaccines are decreasing. The dosis need to be of higher efficacy to better deal with other variants before more strains arises. Nasdaq has made a deal in India to put their novavax in operation warp speed to be able to get approved and distributed to other countries", "task_condition": "viz", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 814331, "what": "The story is about the ordeal of Nasdaq to get their vaccine, novavax, approved to use against the virus.", "when_happened": "current_month", "where_location": "Mexico/India", "who": "Nasdaq/Mexico/India", "why": "The story is important so the audience can see how much goes into developing a vaccine and be reassured of it efficacy against covid to ultimately encourage others to get vaccinated."}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_5", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-16 16:39:21", "close_timestamp": 1637080761345, "created": "16/11/2021 16:39:24", "department": "Computing", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "869fd10e-dd21-4b63-98ef-9ecbb24497c3", "open_date_time": "2021-10-16 16:23:41", "open_timestamp": 1637079821803, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "In Austrailia, the GP are asked to prescribed a combination of ivermectin, zinc and doxycycline as a measure to counter attack the corona virus. Australians were waiting for the vaccine and these combinations might save lives of those inflicted with the virus.", "task_condition": "viz", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 939542, "what": "The story is about requesting doctors to start prescribing Ivermectin with a combination of other medicines like zinc to covid patients.", "when_happened": "few_month_ago", "where_location": "Australia", "who": "Doctors/Patients/Government", "why": "The story is important because it talks about the potential of saving lives who are suffering due to covid."}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_5", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-16 17:4:52", "close_timestamp": 1637082292079, "created": "16/11/2021 17:04:55", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "03c59667-1a80-4b72-8439-0fb03936ccb0", "open_date_time": "2021-10-16 16:53:17", "open_timestamp": 1637081597874, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "Japan's Ministry of health has approved the use of a mix of antibodies to treat covid patients with a mild to moderate case of infection. This resulted in Japan being the first country to do so while other countries have only approved it for emergency use. The antibody mix has proven to reduce hospitalization by 70% and have reduced the time where patients displayed symptoms by 4 days. Also, in non clinical studies, it has proven to also aid patients with the new delta variant. ", "task_condition": "text", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 694205, "what": "The story is about Japan's ministry of health being the first country to approve a coctail mix of antibodies to treat mild to moderate cases of coronavirus.", "when_happened": "few_month_ago", "where_location": "Japan", "who": "Japan/Roche/Ronapreve", "why": "The story is important because it creates a spotlight on what other countries are doing to end the pandemic and saves lives. With more governments approving some medication it will pave a way for other governments to do the same."}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_5", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-16 17:58:30", "close_timestamp": 1637085510196, "created": "16/11/2021 17:58:33", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "da49856f-2056-453a-b8df-bd5e6ac102c2", "open_date_time": "2021-10-16 17:41:54", "open_timestamp": 1637084514860, "summary": "Pfizer and BioNTech vaccine collaboration, Comirnaty, has seen huge success with the company reporting 1.5 billion in vaccine sales. Moreover, this is only expected to rise with both the FDA and CDC approving the vaccine usage on adolescence. Furthermore, the UK's medicine and healthcare products Regulatory Agency has also approved a new shelf life of the vaccine which will extend it from 5 days to 31 days which will enable the vaccine to be stored and used in more places making it even more available. The success of Comirnaty has enabled Pfizer to look into the future as leader in the vaccine market and expand their operations. In addition to this, Pfizer is also working on an antiviral medication that will complement vaccines in the fight to stop Covid and the pandemic. ", "task_condition": "text", "task_key": "pfizer", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 995336}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_5", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-16 17:41:41", "close_timestamp": 1637084501446, "created": "16/11/2021 17:41:44", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-16", "gender": "male", "id": "fadf8cfe-e8cc-4e7a-82c9-6ce8effca68c", "open_date_time": "2021-10-16 17:15:10", "open_timestamp": 1637082910888, "summary": "AstraZeneca is now known worldwide for their vaccine now named, Vaxzevria. The British firm has made it possible for their vaccine to be available worldwide. Unfortunately, due to supply issues they have been unable to meet the EU demand of the vaccine which has resulted in the EU seeking legal action of the British company. Moreover, this is not the only problem the company has with its vaccine. In India, their manufacturer of the vaccine has also put a stop to exporting said vaccine due to rapid increase in domestic cases. Furthermore, vaxzevria that is manufactured in India is a part of the covax donation which seeks to donate vaccines to lesser income countries. In addition to this, there are also studies showing that the vaccine might cause blood clots which have hindered the rollout to different countries and age groups. Astra Zenenca is facing many ordeals but one silver lining that will aid the company is that the FDA in the United States is about to approve the drug which would enable to the US to donate part of its supplies to other nation and ultimately stabilize the British company.", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 1590558}}}